NuVasive (NUVA) PT Raised to $72 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Brean Capital Raises Price Target on NuVasive (NUVA) to $70 Following Solid 2Q
July 27, 2016 11:04 AM EDTBrean Capital reiterated a Buy rating on NuVasive (NASDAQ: NUVA), and raised the price target to $70.00 (from $60.00), following the company's 2Q earnings report.
Analyst Jason Wittes commented, "NUVA reported a 16.4% (16.1% cc) revenue increase to $236.2 millionabove consensus and our $233.0 million estimate and was strong... More
NuVasive (NUVA) Tops Q2 EPS by 4c; Guides Abovce
July 26, 2016 4:05 PM EDTNuVasive (NASDAQ: NUVA) reported Q2 EPS of $0.40, $0.04 better than the analyst estimate of $0.36. Revenue for the quarter came in at $236.5 million versus the consensus estimate of $233.01 million.
GUIDANCE:
NuVasive sees FY2016 EPS of $1.64, versus the consensus of $1.51. NuVasive sees FY2016 revenue... More
